Drug intelligence / Profile preview

diphemanil

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Intramuscular, Subcutaneous, Topical
01

Overview

Diphemanil (commonly used as its salt, diphemanil methylsulfate) is a quaternary ammonium anticholinergic drug. It acts primarily as an antagonist at muscarinic acetylcholine receptors, especially the M3 subtype. By blocking these receptors, it decreases secretory excretion of stomach acids, saliva, and sweat. Diphemanil is indicated for the treatment of peptic ulcer disease, gastric hyperacidity, hypermotility in gastritis and pylorospasm, and hyperhidrosis (excessive sweating). Its mechanism involves inhibition of parasympathetic activity in smooth muscle and glandular tissue[1][4][6][8].

Brand names
Prantal
Other names
diphemanil methylsulfatediphemanil metilsulfate
02

Targets

M1 (Muscarinic acetylcholine receptor M1)CHRM3 (M3)

Beyond the preview

Go deeper on diphemanil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on diphemanil.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call